Mouse strain-dependent variation in the course and outcome of chlamydial genital tract infection is associated with differences in host response.

PubWeight™: 2.43‹?› | Rank: Top 2%

🔗 View Article (PMC 175432)

Published in Infect Immun on August 01, 1997

Authors

T Darville1, C W Andrews, K K Laffoon, W Shymasani, L R Kishen, R G Rank

Author Affiliations

1: Department of Pediatric Infectious Diseases, Arkansas Children's Hospital, University of Arkansas for Medical Sciences, Little Rock 72202, USA. toni@achasc.uams.edu

Articles citing this

Immunity to murine chlamydial genital infection. Infect Immun (2002) 4.64

The use of rodent models to investigate host-bacteria interactions related to periodontal diseases. J Clin Periodontol (2008) 2.21

Pathogenesis of genital tract disease due to Chlamydia trachomatis. J Infect Dis (2010) 1.87

Identification of homing receptors that mediate the recruitment of CD4 T cells to the genital tract following intravaginal infection with Chlamydia trachomatis. Infect Immun (1997) 1.84

Frameshift mutations in a single novel virulence factor alter the in vivo pathogenicity of Chlamydia trachomatis for the female murine genital tract. Infect Immun (2010) 1.64

Delayed inflammatory response to primary pneumonic plague occurs in both outbred and inbred mice. Infect Immun (2006) 1.59

Toll-like receptor 2 activation by Chlamydia trachomatis is plasmid dependent, and plasmid-responsive chromosomal loci are coordinately regulated in response to glucose limitation by C. trachomatis but not by C. muridarum. Infect Immun (2011) 1.56

Early local cytokine profiles in strains of mice with different outcomes from chlamydial genital tract infection. Infect Immun (2001) 1.56

The p47 GTPases Igtp and Irgb10 map to the Chlamydia trachomatis susceptibility locus Ctrq-3 and mediate cellular resistance in mice. Proc Natl Acad Sci U S A (2006) 1.49

Inflammasome-dependent caspase-1 activation in cervical epithelial cells stimulates growth of the intracellular pathogen Chlamydia trachomatis. J Biol Chem (2009) 1.37

In situ analysis of the evolution of the primary immune response in murine Chlamydia trachomatis genital tract infection. Infect Immun (2000) 1.36

Vaccination against Chlamydia genital infection utilizing the murine C. muridarum model. Infect Immun (2010) 1.33

Differential regulation of CD4 lymphocyte recruitment between the upper and lower regions of the genital tract during Chlamydia trachomatis infection. Infect Immun (2000) 1.26

Prior genital tract infection with a murine or human biovar of Chlamydia trachomatis protects mice against heterotypic challenge infection. Infect Immun (1999) 1.25

Mouse strain-dependent differences in susceptibility to Neisseria gonorrhoeae infection and induction of innate immune responses. Infect Immun (2009) 1.24

Type I interferon signaling exacerbates Chlamydia muridarum genital infection in a murine model. Infect Immun (2008) 1.23

Expression of mucosal homing receptor alpha4beta7 is associated with enhanced migration to the Chlamydia-infected murine genital mucosa in vivo. Infect Immun (2000) 1.21

Expression of matrix metalloproteinases subsequent to urogenital Chlamydia muridarum infection of mice. Infect Immun (2005) 1.20

The infecting dose of Chlamydia muridarum modulates the innate immune response and ascending infection. Infect Immun (2004) 1.20

Does inhibition of tumor necrosis factor alpha affect chlamydial genital tract infection in mice and guinea pigs? Infect Immun (2000) 1.18

Interleukin-17 contributes to generation of Th1 immunity and neutrophil recruitment during Chlamydia muridarum genital tract infection but is not required for macrophage influx or normal resolution of infection. Infect Immun (2010) 1.18

Inhibition of matrix metalloproteinases protects mice from ascending infection and chronic disease manifestations resulting from urogenital Chlamydia muridarum infection. Infect Immun (2006) 1.17

Role for inducible nitric oxide synthase in protection from chronic Chlamydia trachomatis urogenital disease in mice and its regulation by oxygen free radicals. Infect Immun (2001) 1.15

Critical role of the interleukin-17/interleukin-17 receptor axis in regulating host susceptibility to respiratory infection with Chlamydia species. Infect Immun (2009) 1.13

Effect of Chlamydia trachomatis infection and subsequent tumor necrosis factor alpha secretion on apoptosis in the murine genital tract. Infect Immun (2000) 1.12

Antimicrobial photodynamic inactivation and photodynamic therapy for infections. Methods Mol Biol (2010) 1.11

Mouse strain-dependent chemokine regulation of the genital tract T helper cell type 1 immune response. Infect Immun (2001) 1.11

Protection against ascending infection of the genital tract by Chlamydia trachomatis is associated with recruitment of major histocompatibility complex class II antigen-presenting cells into uterine tissue. Infect Immun (1998) 1.07

Differences in innate immune responses (in vitro) to HeLa cells infected with nondisseminating serovar E and disseminating serovar L2 of Chlamydia trachomatis. Infect Immun (2002) 1.06

A role for matrix metalloproteinase-9 in pathogenesis of urogenital Chlamydia muridarum infection in mice. Microbes Infect (2007) 1.05

A limited role for antibody in protective immunity induced by rCPAF and CpG vaccination against primary genital Chlamydia muridarum challenge. FEMS Immunol Med Microbiol (2009) 1.05

Depletion of CD8+ cells abolishes memory in acquired immunity against Chlamydia pneumoniae in BALB/c mice. Immunology (1999) 1.03

The duration of Chlamydia muridarum genital tract infection and associated chronic pathological changes are reduced in IL-17 knockout mice but protection is not increased further by immunization. PLoS One (2013) 1.00

Murine Chlamydia trachomatis genital infection is unaltered by depletion of CD4+ T cells and diminished adaptive immunity. J Infect Dis (2011) 0.96

Enhanced neutrophil longevity and recruitment contribute to the severity of oviduct pathology during Chlamydia muridarum infection. Infect Immun (2011) 0.96

Disease outcome subsequent to primary and secondary urogenital infection with murine or human biovars of Chlamydia trachomatis. Infect Immun (2000) 0.96

Plasmid-cured Chlamydia caviae activates TLR2-dependent signaling and retains virulence in the guinea pig model of genital tract infection. PLoS One (2012) 0.96

MyD88 deficiency leads to decreased NK cell gamma interferon production and T cell recruitment during Chlamydia muridarum genital tract infection, but a predominant Th1 response and enhanced monocytic inflammation are associated with infection resolution. Infect Immun (2010) 0.95

Differences in innate immune responses correlate with differences in murine susceptibility to Chlamydia muridarum pulmonary infection. Immunology (2009) 0.95

Enhanced virulence of Chlamydia muridarum respiratory infections in the absence of TLR2 activation. PLoS One (2011) 0.94

Host-Cell Survival and Death During Chlamydia Infection. Curr Immunol Rev (2007) 0.93

Differences in growth characteristics and elementary body associated cytotoxicity between Chlamydia trachomatis oculogenital serovars D and H and Chlamydia muridarum. J Clin Pathol (2005) 0.93

Essential role for neutrophils in pathogenesis and adaptive immunity in Chlamydia caviae ocular infections. Infect Immun (2011) 0.90

Animal models for studying female genital tract infection with Chlamydia trachomatis. Infect Immun (2013) 0.90

Less inhibition of interferon-gamma to organism growth in host cells may contribute to the high susceptibility of C3H mice to Chlamydia trachomatis lung infection. Immunology (2004) 0.89

Chlamydia trachomatis polymorphic membrane protein D is a virulence factor involved in early host-cell interactions. Infect Immun (2014) 0.87

Acquired immunity to Chlamydia pneumoniae is dependent on gamma interferon in two mouse strains that initially differ in this respect after primary challenge. Infect Immun (2000) 0.86

The recall response induced by genital challenge with Chlamydia muridarum protects the oviduct from pathology but not from reinfection. Infect Immun (2012) 0.86

Blockade of epithelial membrane protein 2 (EMP2) abrogates infection of Chlamydia muridarum murine genital infection model. FEMS Immunol Med Microbiol (2009) 0.85

Proteomic identification of immunodominant chlamydial antigens in a mouse model. J Proteomics (2012) 0.84

Interruption of CXCL13-CXCR5 axis increases upper genital tract pathology and activation of NKT cells following chlamydial genital infection. PLoS One (2012) 0.83

Vaginal chlamydial clearance following primary or secondary infection in mice occurs independently of TNF-α. Front Cell Infect Microbiol (2013) 0.82

Interferon regulatory transcription factor 3 protects mice from uterine horn pathology during Chlamydia muridarum genital infection. Infect Immun (2011) 0.82

Induction of protective immunity against a Chlamydia trachomatis genital infection in three genetically distinct strains of mice. Immunology (2003) 0.82

Chlamydial infection increases gonococcal colonization in a novel murine coinfection model. Infect Immun (2011) 0.82

Acquired homotypic and heterotypic immunity against oculogenital Chlamydia trachomatis serovars following female genital tract infection in mice. BMC Infect Dis (2005) 0.81

CD4+ T cell expression of MyD88 is essential for normal resolution of Chlamydia muridarum genital tract infection. J Immunol (2013) 0.81

Resistance to chlamydial lung infection is dependent on major histocompatibility complex as well as non-major histocompatibility complex determinants. Immunology (2005) 0.81

Comparable Genital Tract Infection, Pathology, and Immunity in Rhesus Macaques Inoculated with Wild-Type or Plasmid-Deficient Chlamydia trachomatis Serovar D. Infect Immun (2015) 0.79

Budesonide suppresses pulmonary antibacterial host defense by down-regulating cathelicidin-related antimicrobial peptide in allergic inflammation mice and in lung epithelial cells. BMC Immunol (2013) 0.79

Inducible nitric oxide synthase regulates production of isoprostanes in vivo during chlamydial genital infection in mice. Infect Immun (2003) 0.79

Chlamydia caviae infection alters abundance but not composition of the guinea pig vaginal microbiota. Pathog Dis (2015) 0.79

The Chlamydia-Secreted Protease CPAF Promotes Chlamydial Survival in the Mouse Lower Genital Tract. Infect Immun (2016) 0.78

IL-23 induces IL-22 and IL-17 production in response to Chlamydia muridarum genital tract infection, but the absence of these cytokines does not influence disease pathogenesis. Am J Reprod Immunol (2013) 0.78

Lack of an effect of antibiotic treatment on prolonged detection of chlamydial DNA in murine genital tract infection. Antimicrob Agents Chemother (2007) 0.78

Quantitative In Vivo Detection of Chlamydia muridarum Associated Inflammation in a Mouse Model Using Optical Imaging. Mediators Inflamm (2015) 0.77

Immunization with a peptide corresponding to chlamydial heat shock protein 60 increases the humoral immune response in C3H mice to a peptide representing variable domain 4 of the major outer membrane protein of Chlamydia trachomatis. Clin Diagn Lab Immunol (1999) 0.77

Differences in infectivity and induction of infertility: a comparative study of Chlamydia trachomatis strains in the murine model. Microbes Infect (2012) 0.77

Rectal administration of a chlamydial subunit vaccine protects against genital infection and upper reproductive tract pathology in mice. PLoS One (2017) 0.77

Chlamydia muridarum induction of glandular duct dilation in mice. Infect Immun (2015) 0.75

Antibody and Cytokine Responses of Koalas (Phascolarctos cinereus) Vaccinated with Recombinant Chlamydial Major Outer Membrane Protein (MOMP) with Two Different Adjuvants. PLoS One (2016) 0.75

Chlamydial variants differ in ability to ascend the genital tract in the guinea pig model of chlamydial genital infection. Infect Immun (2015) 0.75

Update on Chlamydia trachomatis Vaccinology. Clin Vaccine Immunol (2017) 0.75

Steroids alone or as adjunctive therapy with doxycycline fail to improve oviduct damage in mice infected with Chlamydia muridarum. Clin Vaccine Immunol (2014) 0.75

Chlamydia trachomatis Cellular Exit Alters Interactions with Host Dendritic Cells. Infect Immun (2017) 0.75

Host Nectin-1 Promotes Chlamydial Infection in the Female Mouse Genital Tract, but Is Not Required for Infection in a Novel Male Murine Rectal Infection Model. PLoS One (2016) 0.75

Outcome of urogenital infection with Chlamydia muridarum in CD14 gene knockout mice. BMC Infect Dis (2006) 0.75

The Predominant CD4+ Th1 Cytokine Elicited to Chlamydia trachomatis Infection in Women is Tumor Necrosis Factor-Alpha, not Interferon-Gamma. Clin Vaccine Immunol (2017) 0.75

A Protective Vaccine against Chlamydia Genital Infection Using Vault Nanoparticles without an Added Adjuvant. Vaccines (Basel) (2017) 0.75

CCR7 Deficiency Allows Accelerated Clearance of Chlamydia from the Female Reproductive Tract. J Immunol (2017) 0.75

Articles cited by this

Purification and partial characterization of the major outer membrane protein of Chlamydia trachomatis. Infect Immun (1981) 18.13

Genital chlamydial infections: epidemiology and reproductive sequelae. Am J Obstet Gynecol (1991) 6.49

Secretion of proinflammatory cytokines by epithelial cells in response to Chlamydia infection suggests a central role for epithelial cells in chlamydial pathogenesis. J Clin Invest (1997) 4.51

Chlamydia trachomatis infections in the United States. What are they costing us? JAMA (1987) 3.32

Intravaginal inoculation of mice with the Chlamydia trachomatis mouse pneumonitis biovar results in infertility. Infect Immun (1994) 2.73

A role in vivo for tumor necrosis factor alpha in host defense against Chlamydia trachomatis. Infect Immun (1990) 2.55

Pelvic inflammatory disease. N Engl J Med (1994) 2.34

Genetically determined differences in IL-10 and IFN-gamma responses correlate with clearance of Chlamydia trachomatis mouse pneumonitis infection. J Immunol (1996) 2.31

Local Th1-like responses are induced by intravaginal infection of mice with the mouse pneumonitis biovar of Chlamydia trachomatis. Infect Immun (1995) 2.28

Salpingitis in mice induced by human strains of Chlamydia trachomatis. Br J Exp Pathol (1986) 2.03

Effect of prior sexually transmitted disease on the isolation of Chlamydia trachomatis. Sex Transm Dis (1987) 1.95

Initial route of antigen administration alters the T-cell cytokine profile produced in response to the mouse pneumonitis biovar of Chlamydia trachomatis following genital infection. Infect Immun (1996) 1.94

Heterotypic protection of mice against chlamydial salpingitis and colonization of the lower genital tract with a human serovar F isolate of Chlamydia trachomatis by prior immunization with recombinant serovar L1 major outer-membrane protein. J Gen Microbiol (1992) 1.77

Chlamydia trachomatis infection of the Fallopian tubes. Histological findings in two patients. Br J Vener Dis (1979) 1.65

Variation in virulence among oculogenital serovars of Chlamydia trachomatis in experimental genital tract infection. Infect Immun (1990) 1.51

Chlamydia trachomatis pneumonia induces in vivo production of interleukin-1 and -6. Infect Immun (1992) 1.33

Tumor necrosis factor alpha activity in genital tract secretions of guinea pigs infected with chlamydiae. Infect Immun (1995) 1.28

The in vitro bactericidal activity of peritoneal and spleen cells from Listeria-resistant and -susceptible mouse strains. Cell Immunol (1986) 1.25

Mutational analysis of TNF-alpha gene reveals a regulatory role for the 3'-untranslated region in the genetic predisposition to lupus-like autoimmune disease. J Immunol (1996) 1.19

Production of colony-stimulating factors during pneumonia caused by Chlamydia trachomatis. Infect Immun (1991) 1.06

Articles by these authors

Genome sequence of Chlamydophila caviae (Chlamydia psittaci GPIC): examining the role of niche-specific genes in the evolution of the Chlamydiaceae. Nucleic Acids Res (2003) 4.33

Identification and characterization of mutations in hepatitis B virus resistant to lamivudine. Lamivudine Clinical Investigation Group. Hepatology (1998) 4.14

Resolution of chlamydial genital infection in B-cell-deficient mice and immunity to reinfection. Infect Immun (1988) 3.55

Humoral immunity in the resolution of genital infection in female guinea pigs infected with the agent of guinea pig inclusion conjunctivitis. Infect Immun (1979) 3.39

Resolution of murine chlamydial genital infection by the adoptive transfer of a biovar-specific, Th1 lymphocyte clone. Reg Immunol (1994) 3.06

A new animal model for the study of Chlamydia trachomatis genital infections: infection of mice with the agent of mouse pneumonitis. J Infect Dis (1981) 3.06

Humoral immune response in acquired immunity to chlamydial genital infection of female guinea pigs. Infect Immun (1983) 2.72

Resolution of chlamydial genital infection with antigen-specific T-lymphocyte lines. Infect Immun (1991) 2.62

Chronic chlamydial genital infection in congenitally athymic nude mice. Infect Immun (1985) 2.54

Role for CD8+ T cells in antichlamydial immunity defined by Chlamydia-specific T-lymphocyte clones. Infect Immun (1994) 2.29

Local Th1-like responses are induced by intravaginal infection of mice with the mouse pneumonitis biovar of Chlamydia trachomatis. Infect Immun (1995) 2.28

Effect of estradiol on chlamydial genital infection of female guinea pigs. Infect Immun (1982) 2.09

Effect of antithymocyte serum on the course of chlamydial genital infection in female guinea pigs. Infect Immun (1983) 2.09

Endoscopic surveillance of Barrett's esophagus. Does it help? J Thorac Cardiovasc Surg (1993) 2.00

Initial route of antigen administration alters the T-cell cytokine profile produced in response to the mouse pneumonitis biovar of Chlamydia trachomatis following genital infection. Infect Immun (1996) 1.94

Identification of homing receptors that mediate the recruitment of CD4 T cells to the genital tract following intravaginal infection with Chlamydia trachomatis. Infect Immun (1997) 1.84

Humoral immune response to chlamydial genital infection of mice with the agent of mouse pneumonitis. Infect Immun (1989) 1.72

Nonsterilizing immunity in avian malaria: an antibody-independent phenomenon. Proc Soc Exp Biol Med (1976) 1.69

Prospective evaluation of early morphological changes in pelvic ileal pouches. Gastroenterology (1994) 1.66

Susceptibility to reinfection after a primary chlamydial genital infection is associated with a decrease of antigen-specific T cells in the genital tract. Infect Immun (1991) 1.58

Role of CD8 T cells in primary Chlamydia infection. Infect Immun (1995) 1.56

Early local cytokine profiles in strains of mice with different outcomes from chlamydial genital tract infection. Infect Immun (2001) 1.56

Target tissues associated with genital infection of female guinea pigs by the chlamydial agent of guinea pig inclusion conjunctivitis. J Infect Dis (1979) 1.54

Analysis of the humoral immune response to chlamydial genital infection in guinea pigs. Infect Immun (1987) 1.53

Experimental chlamydial salpingitis in immunosuppressed guinea pigs infected in the genital tract with the agent of guinea pig inclusion conjunctivitis. Infect Immun (1979) 1.51

Immune response in mice infected in the genital tract with mouse pneumonitis agent (Chlamydia trachomatis biovar). Infect Immun (1984) 1.51

Role of NK cells in early host response to chlamydial genital infection. Infect Immun (1998) 1.48

Humoral and cellular immunity in secondary infection due to murine Chlamydia trachomatis. Infect Immun (1997) 1.43

Decreased expression of Mac-2 (carbohydrate binding protein 35) and loss of its nuclear localization are associated with the neoplastic progression of colon carcinoma. Proc Natl Acad Sci U S A (1993) 1.40

Induction of arthritis in C57B1/6 mice by chlamydial antigen. Effect of prior immunization or infection. Am J Pathol (1988) 1.38

Internalization of Chlamydia by dendritic cells and stimulation of Chlamydia-specific T cells. J Immunol (1998) 1.35

Tumor necrosis factor alpha activity in genital tract secretions of guinea pigs infected with chlamydiae. Infect Immun (1995) 1.28

Differential regulation of CD4 lymphocyte recruitment between the upper and lower regions of the genital tract during Chlamydia trachomatis infection. Infect Immun (2000) 1.26

Partial protection against genital reinfection by immunization of guinea-pigs with isolated outer-membrane proteins of the chlamydial agent of guinea-pig inclusion conjunctivitis. J Gen Microbiol (1993) 1.23

Specific effect of estradiol on the genital mucosal antibody response in chlamydial ocular and genital infections. Infect Immun (1987) 1.22

Expression of mucosal homing receptor alpha4beta7 is associated with enhanced migration to the Chlamydia-infected murine genital mucosa in vivo. Infect Immun (2000) 1.21

Chronic infection with Trypanosoma musculi in congenitally athymic nude mice. Infect Immun (1977) 1.19

Does inhibition of tumor necrosis factor alpha affect chlamydial genital tract infection in mice and guinea pigs? Infect Immun (2000) 1.18

Cystitis associated with chlamydial infection of the genital tract in male guinea pigs. Sex Transm Dis (1981) 1.18

Persistent chlamydial envelope antigens in antibiotic-exposed infected cells trigger neutrophil chemotaxis. J Infect Dis (1999) 1.17

Effects of various doses of estradiol on chlamydial genital infection in ovariectomized guinea pigs. Sex Transm Dis (1985) 1.17

Prevention of recrudescent malaria in nude mice by thymic grafting or by treatment with hyperimmune serum. Infect Immun (1977) 1.15

Integrin-mediated epithelial-T cell interaction enhances nitric oxide production and increased intracellular inhibition of Chlamydia. J Leukoc Biol (1996) 1.12

Mouse strain-dependent chemokine regulation of the genital tract T helper cell type 1 immune response. Infect Immun (2001) 1.11

Regional immunosuppression induced by Plasmodium berghei yoelii infection in mice. Infect Immun (1975) 1.09

An in vitro model for immune control of chlamydial growth in polarized epithelial cells. Infect Immun (1994) 1.08

A role for interleukin-6 in host defense against murine Chlamydia trachomatis infection. Infect Immun (1998) 1.05

Absence of progesterone effects on chlamydial genital infection in female guinea pigs. Sex Transm Dis (1985) 1.02

Radical changes to chlamydial taxonomy are not necessary just yet. Int J Syst Evol Microbiol (2001) 0.99

Inhibition of intracellular multiplication of human strains of Chlamydia trachomatis by nitric oxide. Biochem Biophys Res Commun (1997) 0.99

Chlamydial salpingitis in female guinea pigs receiving oral contraceptives. Sex Transm Dis (1989) 0.98

Novel benzophenones as non-nucleoside reverse transcriptase inhibitors of HIV-1. J Med Chem (2004) 0.98

Role of gamma-delta T cells in murine Chlamydia trachomatis infection. Infect Immun (1996) 0.97

Ultrastructural studies of chlamydial infection in guinea-pig urogenital tract. J Comp Pathol (1982) 0.94

Chlamydia trachomatis pneumonia in the severe combined immunodeficiency (SCID) mouse. Reg Immunol (1994) 0.92

Molecular diversity in chemical databases: comparison of medicinal chemistry knowledge bases and databases of commercially available compounds. J Chem Inf Comput Sci (1996) 0.91

Immunity to reinfection and immunization of male guinea pigs against urethral infection with the agent of guinea pig inclusion conjunctivitis. Sex Transm Dis (1997) 0.88

Electron microscopic observations concerning the in vivo uptake and release of the agent of guinea-pig inclusion conjunctivitis (Chlamydia psittaci) in guinea-pig exocervix. J Comp Pathol (1985) 0.87

2-[(arylmethyl) amino]-2-methyl-1,3-propanediol DNA intercalators. An examination of the effects of aromatic ring variation on antitumor activity and DNA binding. J Med Chem (1991) 0.86

Chlamydial pneumonitis induced in newborn guinea pigs. Infect Immun (1985) 0.86

Splenomegaly in murine trypanosomiasis: T cell-dependent phenomenon. Infect Immun (1979) 0.84

Immunosuppressive effects of experimental infection with Plasmodium gallinaceum. Proc Soc Exp Biol Med (1975) 0.81

Sucrase-isomaltase is an independent prognostic marker for colorectal carcinoma. Dis Colon Rectum (1995) 0.81

Morphology of cholesteryl ester-rich inclusions in lesions of atherosclerosis in man. Atherosclerosis (1974) 0.81

Activation of latent transforming growth factor beta during Chlamydia trachomatis-induced murine pneumonia. Res Microbiol (1996) 0.81

Protection against Chlamydia trachomatis infection in vitro and modulation of inflammatory response in vivo by membrane-bound glycosaminoglycans. Microbes Infect (2004) 0.80

Chlamydia trachomatis infection does not enhance local cellular immunity against concurrent Candida vaginal infection. Infect Immun (2001) 0.80

Intravenous immunoglobulin inhibits staphylococcal toxin-induced human mononuclear phagocyte tumor necrosis factor alpha production. Infect Immun (1997) 0.80

Pathogenesis of acute arthritis due to viable Chlamydia trachomatis (mouse pneumonitis agent) in C57Bl/6 mice. Am J Pathol (1989) 0.79

A comparison of the conformations of the 5'-triphosphates of zidovudine (AZT) and thymidine bound to HIV-1 reverse transcriptase. Biochem Biophys Res Commun (1993) 0.79

Allergic contact dermatitis to low molecular weight allergens in the chicken. Int Arch Allergy Appl Immunol (1976) 0.78

DNA intercalation and inhibition of topoisomerase II. Structure-activity relationships for a series of amiloride analogs. J Biol Chem (1989) 0.77

Response of guinea pigs to intravaginal inoculation with guinea pig cytomegalovirus. Sex Transm Dis (1989) 0.77

Conformation and local environment of nucleotides bound to HIV type 1 reverse transcriptase (HIV-1 RT) in the ground state. Nucleosides Nucleotides Nucleic Acids (2000) 0.77

Molecular characterization of guinea - pig (Cavia porcellus) CD8alpha and CD8beta cDNA. Tissue Antigens (2004) 0.76

Tumor localization of a radiolabeled bombesin analogue in mice bearing human ovarian tumors induced to express the gastrin-releasing peptide receptor by an adenoviral vector. Cancer (1997) 0.75

Age and growth of the American eel (Anguilla rostrata (LeSueur)) in Newfoundland waters. Can J Zool (1971) 0.75

4-(Heteroarylthio)-2-biphenylyltetrazoles as nonpeptide angiotensin II antagonists. J Med Chem (1995) 0.75

Imidazo[5,1-f][1,2,4]triazin-2-amines as novel inhibitors of polo-like kinase 1. Bioorg Med Chem Lett (2008) 0.75